Amelie Plymoth

6.5k total citations · 1 hit paper
28 papers, 3.9k citations indexed

About

Amelie Plymoth is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Amelie Plymoth has authored 28 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 10 papers in Hepatology and 6 papers in Molecular Biology. Recurrent topics in Amelie Plymoth's work include Hepatitis B Virus Studies (12 papers), Liver Disease Diagnosis and Treatment (9 papers) and Hepatitis C virus research (4 papers). Amelie Plymoth is often cited by papers focused on Hepatitis B Virus Studies (12 papers), Liver Disease Diagnosis and Treatment (9 papers) and Hepatitis C virus research (4 papers). Amelie Plymoth collaborates with scholars based in Sweden, United States and France. Amelie Plymoth's co-authors include Pierre Hainaut, Lewis R. Roberts, Gregory J. Gores, Amina Amadou, Ju Dong Yang, Suleeporn Sangrajrang, Laura Beretta, Ziding Feng, Shaokui Ge and Jorge A. Marrero and has published in prestigious journals such as PLoS ONE, Hepatology and Environmental Health Perspectives.

In The Last Decade

Amelie Plymoth

27 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A global view of hepatocellular carcinoma: trends, risk, prevention and management

2019 2.9k citations Ju Dong Yang, Pierre Hainaut et al. Nature Reviews Gastroenterology & Hepatology profile →

Peers

Countries citing papers authored by Amelie Plymoth

Since Specialization

Citations

This map shows the geographic impact of Amelie Plymoth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amelie Plymoth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amelie Plymoth more than expected).

Fields of papers citing papers by Amelie Plymoth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amelie Plymoth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amelie Plymoth. The network helps show where Amelie Plymoth may publish in the future.

Co-authorship network of co-authors of Amelie Plymoth

This figure shows the co-authorship network connecting the top 25 collaborators of Amelie Plymoth. A scholar is included among the top collaborators of Amelie Plymoth based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amelie Plymoth. Amelie Plymoth is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	GALAD Score for the Diagnosis of Hepatocellular Carcinoma in Sub-Saharan Africa: A Validation Study in Ghanaian Patients 2024 ·Cancer Research Communications ·Yvonne Ayerki Nartey, Ju Dong Yang, Tyler Zemla, (unknown), Shadrack Osei Asibey, Mohamed El‐Kassas, (unknown), Amoako Duah, Adwoa Agyei‐Nkansah, Yaw Asante Awuku, Mary Afihene, (unknown), Jun Yin, Amelie Plymoth, Lewis R. Roberts	2
2	A nationwide cross-sectional review of in-hospital hepatitis B virus testing and disease burden estimation in Ghana, 2016 - 2021 2022 ·BMC Public Health ·Yvonne Ayerki Nartey, (unknown), (unknown), (unknown), (unknown), (unknown), Amoako Duah, Alex Owusu‐Ofori, (unknown), (unknown), (unknown), Lindsey Hiebert, Henry Njuguna, John W. Ward, Amelie Plymoth, Lewis R. Roberts, (unknown), Yaw Asante Awuku, Dorcas Obiri‐Yeboah	9
3	Ambulatory end-stage liver disease in Ghana; patient profile and utility of alpha fetoprotein and aspartate aminotransferase: platelet ratio index 2020 ·BMC Gastroenterology ·Yvonne Ayerki Nartey, Yaw Asante Awuku, Adwoa Agyei‐Nkansah, Amoako Duah, (unknown), (unknown), Shadrack Osei Asibey, Niklas K. Björkström, Weimin Ye, Mary Afihene, Lewis R. Roberts, Amelie Plymoth	9
4	A global view of hepatocellular carcinoma: trends, risk, prevention and management breakdown → 2019 ·Nature Reviews Gastroenterology & Hepatology ·Ju Dong Yang, Pierre Hainaut, Gregory J. Gores, Amina Amadou, Amelie Plymoth, Lewis R. Roberts	2931
5	Hepatitis B mother-to-child transmission in the Eastern Region of Ghana: a cross-sectional pilot study 2019 ·Pan African Medical Journal ·Thomas Hambridge, Yvonne Ayerki Nartey, Amoako Duah, Amelie Plymoth	7
6	Nutritional management of cirrhosis patients: A qualitative study exploring perceptions of patients and health workers in Ghana 2019 ·Clinical Nutrition ESPEN ·Yvonne Ayerki Nartey, (unknown), Adwoa Agyei‐Nkansah, Yaw Asante Awuku, (unknown), Amoako Duah, (unknown), (unknown), Shadrack Osei Asibey, Weimin Ye, Mary Afihene, Lewis R. Roberts, Amelie Plymoth	3
7	Physical activity, sleep and risk of respiratory infections: A Swedish cohort study 2018 ·PLoS ONE ·Francesca Ghilotti, (unknown), Sara Raposo, Henric Winell, Olof Nyrén, Ylva Trolle Lagerros, Amelie Plymoth	16
8	Very hot tea drinking increases esophageal squamous cell carcinoma risk in a high-risk area of China: a population-based case–control study 2018 ·Clinical Epidemiology ·Xiaorong Yang, Yingchun Ni, Ziyu Yuan, Hui Chen, Amelie Plymoth, Jin Li, Xingdong Chen, Ming Lü, Weimin Ye	30
9	Intake of vitamin C, vitamin E, selenium, zinc and polyunsaturated fatty acids and upper respiratory tract infection—a prospective cohort study 2017 ·European Journal of Clinical Nutrition ·Sara Raposo, Elinor Fondell, Peter Ström, Olle Bälter, Stephanie E. Bonn, Olof Nyrén, Amelie Plymoth, Katarina Bälter	14
10	Prevalence of gastro-esophageal reflux disease and its risk factors in a community-based population in southern India 2016 ·BMC Gastroenterology ·Haiyun Wang, (unknown), Amelie Plymoth, Maria‐Pia Hergens, Li Yin, (unknown), Weimin Ye	55
11	Aflatoxin-Induced TP53 R249S Mutation in HepatoCellular Carcinoma in Thailand: Association with Tumors Developing in the Absence of Liver Cirrhosis 2012 ·PLoS ONE ·Stéphanie Villar, Sandra Ortiz‐Cuaran, Behnoush Abedi‐Ardekani, Doriane Gouas, André Nogueira da Costa, Amelie Plymoth, Thiravud Khuhaprema, (unknown), Suleeporn Sangrajrang, Marlin D. Friesen, John D. Groopman, Pierre Hainaut	41
12	Association between HBX status, aflatoxin-induced R249S TP53 mutation and risk of hepatocellular carcinoma in a case-control study from Thailand 2012 ·Cancer Letters ·Sandra Ortiz‐Cuaran, Stéphanie Villar, Doriane Gouas, Gilles Ferro, Amelie Plymoth, Thiravud Khuhaprema, (unknown), Suleeporn Sangrajrang, Marlin D. Friesen, John D. Groopman, Pierre Hainaut	25
13	Identification of Osteopontin as a Novel Marker for Early Hepatocellular Carcinoma 2011 ·Hepatology ·(unknown), Amelie Plymoth, Shaokui Ge, Ziding Feng, Hugo R. Rosen, Suleeporn Sangrajrang, Pierre Hainaut, Jorge A. Marrero, Laura Beretta	269
14	Seasonal Variation in TP53 R249S -Mutated Serum DNA with Aflatoxin Exposure and Hepatitis B Virus Infection 2011 ·Environmental Health Perspectives ·Stéphanie Villar, (unknown), Doriane Gouas, Amelie Plymoth, Gilles Ferro, Mathieu Boniol, (unknown), Ebrima Bah, Andrew J. Hall, Christopher P. Wild, Maimuna Mendy, Heléne Norder, Marianne A. B. van der Sande, Hilton Whittle, Marlin D. Friesen, John D. Groopman, Pierre Hainaut	29
15	Proteomics beyond proteomics: toward clinical applications 2010 ·Current Opinion in Oncology ·Amelie Plymoth, Pierre Hainaut	20
16	Control of hepatocellular carcinoma through Hepatitis B vaccination in areas of high endemicity: Perspectives for global liver cancer prevention 2009 ·Cancer Letters ·Amelie Plymoth, Simonetta Viviani, Pierre Hainaut	43
17	Recent advances in p53 research: an interdisciplinary perspective 2008 ·Cancer Gene Therapy ·Magali Olivier, Audrey Petitjean, Virginie Marcel, (unknown), Mounia Mounawar, Amelie Plymoth, Claude Caron de Fromentel, Pierre Hainaut	124
18	Protein Expression Patterns Associated with Progression of Chronic Obstructive Pulmonary Disease in Bronchoalveolar Lavage of Smokers 2007 ·Clinical Chemistry ·Amelie Plymoth, Claes-Göran Löfdahl, Ann Ekberg‐Jansson, Magnus Dahlbäck, Per Broberg, Martyn Foster, Thomas E. Fehniger, György Marko‐Varga	36
19	Analysis and Understanding of High-Dimensionality Data by Means of Multivariate Data Analysis 2005 ·Chemistry & Biodiversity ·Bo Nordén, Per Broberg, (unknown), Amelie Plymoth	42
20	Human bronchoalveolar lavage: Biofluid analysis with special emphasis on sample preparation 2003 ·PROTEOMICS ·Amelie Plymoth, Claes‐Göran Löfdahl, Ann Ekberg‐Jansson, Magnus Dahlbäck, Henrik Lindberg, Thomas E. Fehniger, György Marko‐Varga	56

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact